Emerald Advisers, LLC Imago Bio Sciences, Inc. Transaction History

Emerald Advisers, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 25, 2022	BUY	$14.15 - $19.5 $432,636 - $596,212	30,575 Added 3.71%	853,637 $12.8 Million
Q2 2022 Jul 29, 2022	BUY	$11.81 - $20.92 $2.44 Million - $4.32 Million	206,694 Added 33.53%	823,062 $11 Million
Q1 2022 Apr 29, 2022	BUY	$16.97 - $25.0 $682,346 - $1.01 Million	40,209 Added 6.98%	616,368 $11.9 Million
Q4 2021 Feb 02, 2022	BUY	$16.22 - $29.69 $66,988 - $122,619	4,130 Added 0.72%	576,159 $13.7 Million
Q3 2021 Oct 28, 2021	BUY	$16.0 - $28.84 $9.15 Million - $16.5 Million	572,029 New	572,029 $11.5 Million

19.3K

Ticker IMGO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,741,600
Description
Imago BioSciences, Inc., a clinical stage biopharmaceutical company, discovers and develops small molecule product candidates that target lysine-specific demethylase 1(LSD1), an enzyme that used in the production of blood cells in the bone marrow. Its lead product candidate is bomedemstat, which is in Phase II clinical trials for the treatment o...

Get notified when there are updates to the investment portfolio of Emerald Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Emerald Advisers, LLC with notifications on news.